These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18798264)

  • 1. Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis.
    Conrotto P; Roesli C; Rybak J; Kischel P; Waltregny D; Neri D; Castronovo V
    Int J Cancer; 2008 Dec; 123(12):2856-64. PubMed ID: 18798264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature.
    Rybak JN; Ettorre A; Kaissling B; Giavazzi R; Neri D; Elia G
    Nat Methods; 2005 Apr; 2(4):291-8. PubMed ID: 15782212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chemical proteomics approach for the identification of accessible antigens expressed in human kidney cancer.
    Castronovo V; Waltregny D; Kischel P; Roesli C; Elia G; Rybak JN; Neri D
    Mol Cell Proteomics; 2006 Nov; 5(11):2083-91. PubMed ID: 16861259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo protein biotinylation and sample preparation for the proteomic identification of organ- and disease-specific antigens accessible from the vasculature.
    Roesli C; Neri D; Rybak JN
    Nat Protoc; 2006; 1(1):192-9. PubMed ID: 17406232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pivotal role of reactivity in the design of novel biotinylation reagents for the chemical-proteomics-based identification of vascular accessible biomarkers.
    Hanke SA; Kerner A; Nadler WM; Trumpp A; Zhang Y; Rösli CP
    J Proteomics; 2016 Jun; 141():57-66. PubMed ID: 27113135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues.
    Turtoi A; Dumont B; Greffe Y; Blomme A; Mazzucchelli G; Delvenne P; Mutijima EN; Lifrange E; De Pauw E; Castronovo V
    J Proteome Res; 2011 Jul; 10(7):3160-82. PubMed ID: 21534635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases.
    Rybak JN; Roesli C; Kaspar M; Villa A; Neri D
    Cancer Res; 2007 Nov; 67(22):10948-57. PubMed ID: 18006840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma.
    Turtoi A; Musmeci D; Wang Y; Dumont B; Somja J; Bevilacqua G; De Pauw E; Delvenne P; Castronovo V
    J Proteome Res; 2011 Sep; 10(9):4302-13. PubMed ID: 21755970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of the novel proinflammatory adipokines lipocalin-2, chitinase-3 like-1 and osteopontin as well as angiogenic-related factors in visceral adipose tissue of patients with colon cancer.
    Catalán V; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Silva C; Rotellar F; Hernández-Lizoain JL; Baixauli J; Valentí V; Pardo F; Salvador J; Frühbeck G
    J Nutr Biochem; 2011 Jul; 22(7):634-41. PubMed ID: 20961744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid determination of antigenic epitopes in human NGAL using NMR.
    Olejniczak ET; Ruan Q; Ziemann RN; Birkenmeyer LG; Saldana SC; Tetin SY
    Biopolymers; 2010 Jul; 93(7):657-67. PubMed ID: 20526991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients.
    Fernández CA; Yan L; Louis G; Yang J; Kutok JL; Moses MA
    Clin Cancer Res; 2005 Aug; 11(15):5390-5. PubMed ID: 16061852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target-specific agents imaging ectopic and orthotopic human pancreatic cancer xenografts.
    Wang W; Lin J; Guha S; Tong Z; Cameron AG; Zhang F; Qiu X; Zou C; Gao X; Mawad ME; Ke S
    Pancreas; 2011 Jul; 40(5):689-94. PubMed ID: 21654540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting metastatic breast cancer cell migration via the synergy of targeted, pH-triggered siRNA delivery and chemokine axis blockade.
    Guo P; You JO; Yang J; Jia D; Moses MA; Auguste DT
    Mol Pharm; 2014 Mar; 11(3):755-65. PubMed ID: 24467226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells.
    Lee HJ; Lee EK; Lee KJ; Hong SW; Yoon Y; Kim JS
    Int J Cancer; 2006 May; 118(10):2490-7. PubMed ID: 16381001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical proteomic and bioinformatic strategies for the identification and quantification of vascular antigens in cancer.
    Strassberger V; Fugmann T; Neri D; Roesli C
    J Proteomics; 2010 Sep; 73(10):1954-73. PubMed ID: 20538087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of specific reachable molecular targets in human breast cancer using a versatile ex vivo proteomic method.
    Castronovo V; Kischel P; Guillonneau F; de Leval L; Deféchereux T; De Pauw E; Neri D; Waltregny D
    Proteomics; 2007 Apr; 7(8):1188-96. PubMed ID: 17372937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.
    Pitteri SJ; Faca VM; Kelly-Spratt KS; Kasarda AE; Wang H; Zhang Q; Newcomb L; Krasnoselsky A; Paczesny S; Choi G; Fitzgibbon M; McIntosh MW; Kemp CJ; Hanash SM
    J Proteome Res; 2008 Apr; 7(4):1481-9. PubMed ID: 18311905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies.
    Kischel P; Waltregny D; Castronovo V
    Expert Rev Proteomics; 2007 Dec; 4(6):727-39. PubMed ID: 18067412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.
    Yokoyama T; Enomoto T; Serada S; Morimoto A; Matsuzaki S; Ueda Y; Yoshino K; Fujita M; Kyo S; Iwahori K; Fujimoto M; Kimura T; Naka T
    Int J Cancer; 2013 Jan; 132(2):472-84. PubMed ID: 22729361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of lipocalin-2 gene by the cancer chemopreventive retinoid 4-HPR.
    Caramuta S; De Cecco L; Reid JF; Zannini L; Gariboldi M; Kjeldsen L; Pierotti MA; Delia D
    Int J Cancer; 2006 Oct; 119(7):1599-606. PubMed ID: 16671099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.